Cargando…
Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
PURPOSE OF REVIEW: This narrative review makes the case for greater efforts to reduce cardiovascular disease (CVD) risk in women with diabetes. RECENT FINDINGS: In a recent meta-analysis including five CVOTs of diabetes medications with 46,606 subjects, women (vs men) with type 2 diabetes had a high...
Autores principales: | Harreiter, Jürgen, Fadl, Helena, Kautzky-Willer, Alexandra, Simmons, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544714/ https://www.ncbi.nlm.nih.gov/pubmed/33033953 http://dx.doi.org/10.1007/s11892-020-01348-2 |
Ejemplares similares
-
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
por: Wang, Xiaowen, et al.
Publicado: (2020) -
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020) -
Revisiting the Diabetes-Heart Failure Connection
por: Wallner, Markus, et al.
Publicado: (2018) -
Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy
por: Kambis, Tyler N., et al.
Publicado: (2021) -
Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes
por: Yoshida, Yilin, et al.
Publicado: (2019)